ArticleEMBO molecular medicinePublished
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
Regional connection
Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source
- Institution
- Children’s Hospital of Philadelphia
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- EMBO molecular medicine
- Published
- Topic
- Disease research
- Subject terms
- Humans; Retinoids; Nicotinic Acids; Sulfatases; Drug Evaluation, Preclinical; Oxidoreductases Acting on Sulfur Group Donors; Multiple Sulfatase Deficiency Disease; Bexarotene; Drug screening; Formylglycine-generating Enzyme; Lysosomal Disorder; Sulfatase-modifying Factor 1
- PubMed ID
- 36789546
- PubMed Central ID
- PMC9994482
- Open access
- Yes, open
- Added to directory
- Source checked